SELL SYK · Thomas H. Kean Jr
Stryker Corporation Common Stock (SYK)
Deliberate position with a committee link
| Inside their committee's jurisdiction |
|
32/32 |
| Isolated decision, not a bulk rebalance |
|
21/22 |
|
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
|
|
2/10 |
| Member's own account |
|
8/8 |
| Committee chair or ranking member |
|
0/8 |
|
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
|
|
0/8 |
|
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
|
|
0/6 |
| Position size |
|
0/3 |
| Leveraged instrument (option) |
|
0/3 |
A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.
It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.
The filing it came from
filed in 27 days Within the 30-day notification window.
No matching purchase on file. This member has no earlier disclosed purchase of SYK in this account, so the position was almost certainly opened before these records begin in 2019. About 45% of sales are in this situation.
This is a sale, and the strategy does not act on it. It records the member closing a position; it is not a short signal and not an instruction to sell. Exiting when members disclose selling, rather than at twelve months, cut in-remit alpha from +4.75% to +2.83% — a cost of 3.91 points on the trades it changed. See the method.
This filing disclosed 6 transactions in total, of which 2 share this trade date (22 Jul 2026).
Few other trades share this date, so this reads as a discrete decision rather than a portfolio sweep.
Filed 18 Aug 2026 · source PDF
Same day: GOOGL
Price
52-week range $281.83 – $390.37. The marker is the entry: the first market open after this filing became public.
Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care di…
| Sector | Healthcare |
| Industry | Medical Devices |
| Analyst range | $315 – $465 |
| Employees | 56,000 |
| Instrument | ST |
| Jurisdiction tags | healthcare |
Inside this member's remit. Their committees cover defenseenergyhealthcaretechnologytelecom
Expressing this with options
An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.
Loading chain…
Outcome
| Held | This trade | S&P 500 | Alpha |
|---|---|---|---|
| 1m | — | — | — |
| 3m | — | — | — |
| 6m | — | — | — |
| 12m 1yr | — | — | — |
| 18m | — | — | — |
| 24m | — | — | — |
| 36m | — | — | — |
| 48m | — | — | — |
| 60m 5yr | — | — | — |
Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. The last 9 rows are blank because those windows have not closed yet: this trade was entered —, so anything longer than that is still running.
Other congressional trades in SYK
| Grade | Date | Member | Side | Amount |
|---|---|---|---|---|
| C | 02 Jun 2026 | Thomas H. Kean Jr | sale partial | $1,001 - $15,000 |
| E | 27 Mar 2026 | Alan Armstrong | sale | $15,001 - $50,000 |
| B | 23 Jan 2026 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| E | 10 Dec 2025 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| B | 20 Nov 2025 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| E | 18 Nov 2025 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| E | 17 Oct 2025 | Gilbert Cisneros | purchase | $1,001 - $15,000 |
| B | 16 Oct 2025 | Julia Letlow | sale | $1,001 - $15,000 |
| B | 12 Sep 2025 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| B | 25 Aug 2025 | Thomas H. Kean Jr | sale partial | $1,001 - $15,000 |
| B | 31 Jul 2025 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| B | 26 Jun 2025 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| E | 12 May 2025 | Jefferson Shreve | sale | $50,001 - $100,000 |
| E | 17 Apr 2025 | Jefferson Shreve | purchase | $15,001 - $50,000 |
| E | 08 Apr 2025 | Rob Bresnahan | sale | $1,001 - $15,000 |
| E | 08 Apr 2025 | Rob Bresnahan | sale | $1,001 - $15,000 |
| E | 07 Apr 2025 | Julie Johnson | sale | $1,001 - $15,000 |
| E | 07 Apr 2025 | Jared Moskowitz | purchase | $1,001 - $15,000 |
| E | 13 Mar 2025 | Jefferson Shreve | sale partial | $50,001 - $100,000 |
| B | 26 Feb 2025 | Thomas H. Kean Jr | sale partial | $15,001 - $50,000 |
| E | 15 Jan 2025 | Jared Moskowitz | purchase | $1,001 - $15,000 |
| E | 15 Jan 2025 | Jared Moskowitz | purchase | $1,001 - $15,000 |
| C | 23 Oct 2024 | Julia Letlow | purchase | $1,001 - $15,000 |
| E | 24 Oct 2023 | Greg Stanton | sale | $1,001 - $15,000 |
| E | 26 Sep 2023 | Greg Stanton | purchase | $1,001 - $15,000 |
Trade of the